E-Journal WILEY

Anno: 2021A mechanistic model to account for the Donnan and volume exclusion effects in ultrafiltration/diafiltration process of protein formulations ; 2021, Vol. 37, n. 2
Transgenic plants expressing a Clostridium difficile spore antigen as an approach to develop low–cost oral vaccines ; 2021, Vol. 37, n. 3
Prebiotic peptides, their formation, fermentation in the gut, and health implications ; 2021, Vol. 37, n. 3
Process and operations strategies to enable global access to antibody therapies ; 2021, Vol. 37, n. 3
Identification and characterization of a residual host cell protein hexosaminidase B associated with N–glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody product ; 2021, Vol. 37, n. 3
A rapid novel strategy for screening of antibody phage libraries for production, purification, and functional characterization of amber stop codons containing single–chain antibody fragments ; 2021, Vol. 37, n. 3
Antibiofilm effect of mono–rhamnolipids and di–rhamnolipids on carbon steel submitted to oil produced water ; 2021, Vol. 37, n. 3
Two–step sedimentation process for selection of microcapsules containing cell aggregates ; 2021, Vol. 37, n. 3
Application of machine learning methods to pathogen safety evaluation in biological manufacturing processes ; 2021, Vol. 37, n. 3
Effect of nitrate feeding strategies on lipid and biomass productivities in fed–batch cultures of Nannochloropsis gaditana ; 2021, Vol. 37, n. 3
Effect of particle size distribution on filtration performance of cell culture medium ; 2021, Vol. 37, n. 3
Quantification of glycated IgG in CHO supernatants: A practical approach ; 2021, Vol. 37, n. 3
High–capacity multimodal anion–exchange membranes for polishing of therapeutic proteins ; 2021, Vol. 37, n. 3
Structure and binding ability of self–assembled α–lactalbumin protein nanotubular gels ; 2021, Vol. 37, n. 3
Devices and techniques used to obtain and analyze three–dimensional cell cultures ; 2021, Vol. 37, n. 3
Model–based workflow for scale–up of process strategies developed in miniaturized bioreactor systems ; 2021, Vol. 37, n. 3
Anti–epithelial cell adhesion molecule RNA aptamer–conjugated liposomal doxorubicin as an efficient targeted therapy in mice bearing colon carcinoma tumor model ; 2021, Vol. 37, n. 3
In vitro hepatic steatosis model based on gut–liver–on–a–chip ; 2021, Vol. 37, n. 3
Streamlining process characterization efforts using the high throughput ambr® crossflow system for ultrafiltration and diafiltration processing of monoclonal antibodies ; 2021, Vol. 37, n. 3
Safety risk management for low molecular weight process–related impurities in monoclonal antibody therapeutics: Categorization, risk assessment, testing strategy, and process development with leveraging clearance potential ; 2021, Vol. 37, n. 3
Review: High temperature short time treatment of cell culture media and feed solutions to mitigate adventitious viral contamination in the biopharmaceutical industry ; 2021, Vol. 37, n. 3
Modeling flux in tangential flow filtration using a reverse asymmetric membrane for Chinese hamster ovary cell clarification ; 2021, Vol. 37, n. 3
Polyunsaturated fatty acids production by solid–state fermentation on polyurethane foam by Mortierella alpina ; 2021, Vol. 37, n. 3
Retracted: Production, biochemical characterization, and kinetic/thermodynamic study of novel serine protease from Aspergillus avenaceus URM 6706 (Bio. Tech. Prog, 10.1002/btpr.3091) ; 2021, Vol. 37, n. 3
Purification of Pseudomonas sp. proteases through aqueous biphasic systems as an alternative source to obtain bioactive protein hydrolysates ; 2021, Vol. 37, n. 3